| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
A phenothiazine antipsychotic with effects similar to chlorpromazine. [PubChem] |
| Indication |
Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses. |
| Pharmacology |
Mesoridazine, the besylate salt of a metabolite of thioridazine, is a phenothiazine tranquilizer. Pharmacological studies in laboratory animals have established that mesoridazine has a spectrum of pharmacodynamic actions typical of a major tranquilizer. In common with other tranquilizers it inhibits spontaneous motor activity in mice, prolongs thiopental and hexobarbital sleeping time in mice and produces spindles and block of arousal reaction in the EEG of rabbits. It is effective in blocking spinal reflexes in the cut and antagonizes d-amphetamine excitation and toxicity in grouped mice. It shows a moderate adrenergic blocking activity in vitro and in vivo and antagonizes 5-hydroxytryptamine in vivo. Intravenously administered, it lowers the blood pressure of anesthetized dogs. It has a weak antiacetylcholine effect in vitro. |
| Toxicity |
Oral LD50 is 560 ± 62.5 mg/kg and 644 ± 48 mg/kg in mouse and rat, respectively. Symptoms of overdose may include emesis, muscle tremors, decreased food intake and death associated with aspiration of oral-gastric contents into the respiratory system. |
| Affected Organisms |
| • |
Humans and other mammals |
|
| Absorption |
Well absorbed from the gastrointestinal tract. |
| Half Life |
24 to 48 hours |
| Protein Binding |
4% |
| External Links |
|